The role of qualification and quality management in the prescription of antipsychotics and potentially inappropriate medication (PIM) in nursing home residents in Germany: results of the HIOPP-3-iTBX study.

Journal Information

Full Title: Aging Clin Exp Res

Abbreviation: Aging Clin Exp Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Geriatrics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestOn behalf of all authors, the corresponding author states that there is no conflict of interest. Ethical approvalThe Ethics Committee of the Hannover Medical University approved the Masters Ethics Application (No. 7655). Statement of human and animal rightsThis study was performed in line with the principles of the Declaration of Helsinki and results are reported in regard of the CONSORT Statement. The Medical Research Council (MRC) Guideline “Developing and evaluating complex interventions—new guidance” was applied in the intervention development. Informed consentInformed consent was obtained from all individual participants included in the study or their legal guardians. Conflict of interest On behalf of all authors, the corresponding author states that there is no conflict of interest."

Evidence found in paper:

"Funding Open Access funding enabled and organized by Projekt DEAL. This study was funded by the Innovation Fund of the Joint Federal Committee (Grant No.: 01VSF16017). The study was registered in the German Register of Clinical Trials (DRKS00013588)."

Evidence found in paper:

"Funding: Open Access funding enabled and organized by Projekt DEAL. This study was funded by the Innovation Fund of the Joint Federal Committee (Grant No.: 01VSF16017). The study was registered in the German Register of Clinical Trials (DRKS00013588)."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025